Catalog No.
YHJ77001
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Met1-Asn139
Predicted molecular weight
42.96 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q9UHV8
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Gal-13, PLAC8, Placental tissue protein 13, LGALS13, PP13, Galactoside-binding soluble lectin 13, Galectin-13, Placental protein 13
Copy number variation and clinical response to chemotherapy and bevacizumab in the Czech metastatic colorectal cancer patients., PMID:39174331
Placental Protein 13 and Syncytiotrophoblast Basement Membrane Ultrastructures in Preeclampsia., PMID:39064506
Placental Protein 13: Vasomodulatory Effects on Human Uterine Arteries and Potential Implications for Preeclampsia., PMID:39062763
Galectin-13 and Laeverin Levels Interfere with Human Fetoplacental Growth., PMID:38928055
[Predictive value of serum Gal-13, GLP-1 and VEGF levels in adverse pregnancy outcomes of gestational diabetes mellitus]., PMID:38186168
Pregnancy-specific beta-1-glycoprotein 6 is a potential novel diagnostic biomarker of placenta accreta spectrum., PMID:37831187
Intronic variants of LGALS13 gene encoding placental protein (PP13) are linked with increased risk of infection-associated spontaneous preterm birth., PMID:37641375
Augmented Placental Protein 13 in Placental-Associated Extracellular Vesicles in Term and Preterm Preeclampsia Is Further Elevated by Corticosteroids., PMID:37569423
PLACENTAL BIOMARKERS: PP13, VEGF IN DIAGNOSTICS OF EARLY AND LATE PREECLAMPSIA., PMID:36723324
Cadmium inhibits forskolin-induced differentiation of human placental BeWo cells., PMID:35908931
[Expression of galectin-13 in allergic diseases involving airway, skin and mucous membranes]., PMID:35785865
Transcriptomic analysis of primate placentas and novel rhesus trophoblast cell lines informs investigations of human placentation., PMID:34154587
Actin binding to galectin-13/placental protein-13 occurs independently of the galectin canonical ligand-binding site., PMID:34080003
Increased epithelial galectin-13 expression associates with eosinophilic airway inflammation in asthma., PMID:34075657
Overexpression of Galectin10 Predicts a Better Prognosis in Human Ovarian Cancer., PMID:33854625
Proteomic profiling of human uterine extracellular vesicles reveal dynamic regulation of key players of embryo implantation and fertility during menstrual cycle., PMID:33634576
Examining Sex Differences in the Human Placental Transcriptome During the First Fetal Androgen Peak., PMID:33150487
New predictors of early impaired placentation preceding miscarriage before 10 weeks of gestation in IVF pregnancies: A prospective study., PMID:32814235
Placental Protein 13 (Galectin-13) Polarizes Neutrophils Toward an Immune Regulatory Phenotype., PMID:32117288
Galectin-13/placental protein 13: redox-active disulfides as switches for regulating structure, function and cellular distribution., PMID:31584064
Galectin 13 (PP13) Facilitates Remodeling and Structural Stabilization of Maternal Vessels during Pregnancy., PMID:31261864
Maternal Serum Concentrations of Corin, Endoglin, PP13, and sFlt-1 and their Changes with Advancement of Pregnancy and Correlation with Doppler of Uterine Arteries., PMID:31188762
Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration., PMID:30988643
Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction., PMID:30622442
Biology of preeclampsia: Combined actions of angiogenic factors, their receptors and placental proteins., PMID:30553017
Resetting the ligand binding site of placental protein 13/galectin-13 recovers its ability to bind lactose., PMID:30413611
Impact of vitamin D and vitamin D receptor on the trophoblast survival capacity in preeclampsia., PMID:30408071
Placental protein 13: An important biological protein in preeclampsia., PMID:30023011
Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits., PMID:30013317
Reduced placental protein 13 (PP13) in placental derived syncytiotrophoblast extracellular vesicles in preeclampsia - A novel tool to study the impaired cargo transmission of the placenta to the maternal organs., PMID:29884298
Galectin-13, a different prototype galectin, does not bind β-galacto-sides and forms dimers via intermolecular disulfide bridges between Cys-136 and Cys-138., PMID:29343868
Early second trimester maternal serum markers in the prediction of gestational diabetes mellitus., PMID:29288571
Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers., PMID:29275822
Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function., PMID:29034064
Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age., PMID:28728156
Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia., PMID:28704180
First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction., PMID:28600048
Elevated maternal placental protein 13 serum levels at term of pregnancy in postpartum major hemorrhage (>1000 mLs). A prospective cohort study., PMID:28508390
Evaluation of fetal hypermethylated RASSF1A in pre-eclampsia and its relationship with placental protein-13, pregnancy associated plasma protein-A and urine protein., PMID:27939474
Developing a new algorithm for first and second trimester preeclampsia screening in twin pregnancies., PMID:27835040
New Predictive Model at 11+0 to 13+6 Gestational Weeks for Early-Onset Preeclampsia With Fetal Growth Restriction., PMID:27678097
Altered Biomarkers in Trophoblast Cells Obtained Noninvasively Prior to Clinical Manifestation of Perinatal Disease., PMID:27660926
Plasma PP13 and urinary GAGs/PGs as early markers of pre-eclampsia., PMID:27161490
Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR)., PMID:27070577
Relationship between first-trimester serum placental protein-13 and maternal characteristics, placental Doppler studies and pregnancy outcome., PMID:26910737
The endocannabinoid 2-arachidonoylglycerol dysregulates the synthesis of proteins by the human syncytiotrophoblast., PMID:26698196
Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis., PMID:26404264
Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis., PMID:26303460
The endocannabinoid anandamide affects the synthesis of human syncytiotrophoblast-related proteins., PMID:26202891
Pulsatility index in combination with biomarkers or mean arterial pressure for the prediction of pre-eclampsia: Systematic literature review and meta-analysis., PMID:26153822
For research use only. Not for human or drug use.
